Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
1.14 EUR | +2.52% | -1.72% | -16.79% |
Mar. 28 | Transgene CFO Steps Down; Successor Assumes Office | MT |
Mar. 27 | Transcript : Transgene SA, 2023 Earnings Call, Mar 27, 2024 |
Sales 2023 | 7.9M 8.51M | Sales 2024 * | 39.8M 42.86M | Capitalization | 115M 123M |
---|---|---|---|---|---|
Net income 2023 | -22M -23.69M | Net income 2024 * | -13M -14M | EV / Sales 2023 | 17.4 x |
Net Debt 2023 * | 1.9M 2.05M | Net Debt 2024 * | 16.4M 17.66M | EV / Sales 2024 * | 3.29 x |
P/E ratio 2023 |
-6.23
x | P/E ratio 2024 * |
-8.14
x | Employees | 143 |
Yield 2023 * |
-
| Yield 2024 * |
-
| Free-Float | 34.72% |
Latest transcript on Transgene
1 day | +2.52% | ||
1 week | -1.72% | ||
Current month | +9.62% | ||
1 month | +10.68% | ||
3 months | -16.91% | ||
6 months | -26.17% | ||
Current year | -16.79% |
Managers | Title | Age | Since |
---|---|---|---|
Alessandro Riva
CEO | Chief Executive Officer | 63 | 22-03-30 |
Lucie Larguier
DFI | Director of Finance/CFO | - | 16-03-31 |
Maud Brandely
CTO | Chief Tech/Sci/R&D Officer | 70 | 16-03-16 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 74 | 13-06-18 | |
Director/Board Member | 63 | 04-12-06 | |
Benoît Habert
BRD | Director/Board Member | 59 | 99-12-31 |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 1.14 | +2.52% | 56,363 |
24-03-27 | 1.112 | +0.18% | 18,392 |
24-03-26 | 1.11 | +0.36% | 5,793 |
24-03-25 | 1.106 | -2.30% | 23,777 |
24-03-22 | 1.132 | -2.41% | 3,802 |
Real-time Euronext Paris, March 28, 2024 at 12:08 pm EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-16.79% | 124M | |
+2.73% | 108B | |
+9.59% | 103B | |
+6.58% | 23.48B | |
-12.59% | 21.93B | |
-3.29% | 19.68B | |
-35.36% | 18.37B | |
-13.29% | 16.33B | |
+4.68% | 13.72B | |
+34.25% | 12.15B |